Prognostic Factor of Prostate Adenocarcinoma before and after Radical Prostatectomy at a University Hospital

Fernando Nestor Facio Junior, Luís Cesar Fava Spessoto, Márcio Gatti, Pedro Francisco Ferraz Arruda, José Germano Ferraz Arruda, Thiago Antoniassi and Maria Fernanda Warick Facio

International Journal of Sciences, 2015, vol. 4, issue 10, 40-42

Abstract: Introduction: Gleason score is a prognostic factor that assists in the determination of treatment for prostate cancer. The aim of the present study was to investigate the prognostic factor of prostate adenocarcinoma related to the Gleason score before (biopsy) and after radical prostatectomy (RP). Methods: A total of 206 patients with localized prostate adenocarcinoma submitted to RP between 2001 and 2008 at a university hospital were analyzed. Results: The predominant total Gleason score was 6 after biopsy and 7 following RP. The 3+3 pattern after biopsy and 3+4 pattern after RP. Biochemical recurrence was found following RP in 34.9% of cases. In 49% of cases, the Gleason score was lower after biopsy than after RP (p

Keywords: adenocarcinoma; prostatic neoplasms; prognosis; prostatectomy (search for similar items in EconPapers)
Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.ijsciences.com/pub/article/847 (text/html)
https://www.ijsciences.com/pub/pdf/V4201510847.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adm:journl:v:4:y:2015:i:10:p:40-42

Ordering information: This journal article can be ordered from
https://www.ijsciences.com/payment_guide.php

DOI: 10.18483/ijSci.847

Access Statistics for this article

More articles in International Journal of Sciences from Office ijSciences Alkhaer Publications Manchester M8 8XG England.
Bibliographic data for series maintained by Staff ijSciences ().